Brain cancers and the risk of intracranial hemorrhage with DOACs versus Low Molecular Weight Heparin - report from ISTH2022

from Medical Digest & Congress Report · host Medical Congress News

We asked Professor Philip Haddad about anticoagulation treatment of patients with brain tumor. Professor Haddad presented a meta-analysis of the use of DOACs versus LMWH in this indication at the recent ISTH congress Video: https://congressreport.eu/scientific-contents/interview:brain-cancers-and-risk-intracranial-hemorrhage-direct-oral-anticoagulants-versus-low-molecular-weight-heparin

Episode metadata supplied by the publisher feed · Published Jul 22, 2022

Embed this episode

Attribution link and audio player

Ready to play

Brain cancers and the risk of intracranial hemorrhage with DOACs versus Low Molecular Weight Heparin - report from ISTH2022

0:00 5:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 5 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on July 22, 2022.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!